Capital Flow Monitor · Sponsors · CIK 2096102
Polis MedTech Ventures LLC - Series 3
8 THE GREEN, DOVER, DE, 19901 · 480-889-4076
Pooled Investment Fund / Venture Capital Fund · Limited Liability Company· inc. DELAWARE true 2025
Fit score
—
Offering
$2.5M
Sold
$2.5M
% sold
100.0%
Investors
41
Min investment
$1
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2025-11-10 | D ·current | 506(b) | $2.5M | $2.5M | 100.0% | 41 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
-
Matthew Cooper — Director, Dover, DE
5 other raises
- Polis Strategies Fund LLC - Series 5 $1.9M of $1.9M · 100.0%
- Enumera Molecular, Inc. $12.3M of $17.4M · 70.9%
- Allotera Therapeutics, Inc. $123.3M of $163.0M · 75.6%
- Polis Strategies Fund LLC - Series 1 $1.9M of $1.9M · 100.0%
- Polis MedTech Ventures LLC - Series 4 $900K of $900K · 100.0%
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.